132 related articles for article (PubMed ID: 1449115)
1. Treatment of Langerhans cell histiocytosis in children with etoposide.
Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
[TBL] [Abstract][Full Text] [Related]
2. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
Broadbent V; Pritchard J; Yeomans E
Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
[TBL] [Abstract][Full Text] [Related]
3. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
Viana MB; Oliveira BM; Silva CM; Rios Leite VH
Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
[TBL] [Abstract][Full Text] [Related]
4. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
5. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
[TBL] [Abstract][Full Text] [Related]
6. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
[TBL] [Abstract][Full Text] [Related]
8. Treatment of adult Langerhans cell histiocytosis with etoposide.
Tsele E; Thomas DM; Chu AC
J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
10. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
[TBL] [Abstract][Full Text] [Related]
11. Langerhans-cell histiocytosis--excellent response to etoposide.
Mayou SC; Chu AC; Munro DD; Plowman N
Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
[TBL] [Abstract][Full Text] [Related]
12. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S
Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045
[TBL] [Abstract][Full Text] [Related]
15. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
Yu LC; Shenoy S; Ward K; Warrier RP
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
18. Class I histiocytosis: response to combination of etoposide and prednisolone.
Datta V; Mishra OP; Das BK; Kumar M; Bhargava V; Singla PN
Indian Pediatr; 1999 Jan; 36(1):83-6. PubMed ID: 10709128
[No Abstract] [Full Text] [Related]
19. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
Minkov M
Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
